Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...

President Donald Trump on Monday will sign a sweeping executive order that calls on the nation's health department to ...

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

Donald Trump has signed an executive order, described as a “game changer”, which could hit Australia harder than any of his other moves since taking office.

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Even as tariff negotiations are ongoing between Canada and the United States, businesses aren't waiting for good news and are ...

When Canada signed the North American Free Trade Agreement, and the current Canada-United States-Mexico Agreement (CUSMA), ...

Biosimilars are gaining traction as competitors aim to capture market share from branded biologics such as Humira and Neulasta. Humira now faces competition from seven biosimilars, while Neulasta has ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

The foundations of psychedelic capitalism were largely created by public innovation at the public’s expense and are now in ...

We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take ...